Join to View Full Profile
535 Barnhill Dr# ROUTE473Indianapolis, IN 46202
Phone+1 317-274-3960
Dr. Miller is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1994 - 1997
Johns Hopkins UniversityResidency, Internal Medicine, 1991 - 1994- Johns Hopkins University School of MedicineClass of 1991
Certifications & Licensure
IN State Medical License 1994 - 2027
MN State Medical License 1997 - 1999
ND State Medical License 1997 - 1999
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PowerChart, Cerner Healthe, Cerner Patient Portal, HealthSentry and P2 Sentinel, Cerner Corporation, 2014-2015
- CMS Meaningful Use Stage 1 Certification FirstNet, Cerner Healthe and IQHealth, Cerner Corporation, 2014-2015
- CMS Meaningful Use Stage 1 Certification HealthSentry, Cerner Corporation, 2014-2015
Clinical Trials
- Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer Start of enrollment: 2002 Jan 29
- A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer Start of enrollment: 2005 Sep 01
- A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast Cancer Treatment Start of enrollment: 2007 Apr 01
Publications & Presentations
PubMed
- Impact of patient-reported taxane-induced peripheral neuropathy on dose reductions or worsening quality of life in Black women with breast cancer: Analysis from ECOG-A...Tarah J Ballinger, Fengmin Zhao, Guanglong Jiang, Fei Shen, David Cella
Cancer. 2026-06-01 - A phase 1 study of ASTX727 plus talazoparib in patients with triple-negative or hormone resistant/HER2-negative metastatic breast cancer.Kathy D Miller, Alexandra Thomas, Sandra Althouse, Yong Zang, Erin Conder
Cancer. 2026-04-15 - Impact of Race, Socioeconomic Status, and Clinicopathologic Features on Clinical Outcomes in Triple-Negative Breast Cancer in the ECOG-ACRIN EA1131 Trial.Moriah Forster, Fengmin Zhao, Sarah Bell, Ingrid A Mayer, Carlos L Arteaga
JCO Oncology Advances. 2026-04-01
Journal Articles
- Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy with Disease Recurrence in Patients with Triple-Negative Breast CancerRita Nanda, Carla Falkson, Filipa C Lynce, Claudine Isaacs, Marcelo Blaya, Elisavet Paplomata, Radhika Walling, Reshma Mahtani, Tarah J Ballinger, Kathy D Miller, Brya..., JAMA Oncology
Lectures
- Using the Neoadjuvant Approach in Developing Novel Therapies in ER+ Breast Cancer2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
- Review and Interpretation of the 2012 San Antonio Breast Cancer SymposiumIndiana University School of Medicine, Indianapolis, Indiana - 1/19/2013
- 2012 ACCA Northeast Regional ConferenceAmerican Academy of Medical Administrators (AAMA), Wynnewood, Pennsylvania - 10/12/2012
Authored Content
- Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy with Disease Recurrence in Patients with Triple-Negative Breast CancerJuly 2020
Press Mentions
Does Tumor Type Matter? Data Challenge Tumor-Agnostic Approach in Cancer TherapyNovember 18th, 2025- Rethinking Ribociclib: Is 400 Mg Noninferior to 600 Mg for Metastatic Breast Cancer?November 11th, 2025
- More Evidence for Lower Ribociclib Dose in Advanced Breast CancerSeptember 25th, 2025
Grant Support
- Building upon a tradition of excellence. The NCTN at IUSCCCINDIANA UNIVERSITY INDIANAPOLIS2026–2032
- The impact of oxygen exposure on clinical biomarkers - an underrecognized source of pre-analytic variabilityINDIANA UNIVERSITY INDIANAPOLIS2024–2029
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
